Travere Therapeutics, Inc. TVTX

59.44 (1.18) (1.95%) as of 25 Sep
Market cap
$5.7B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
322.80 370.70 566.85 450.25 552.88 361.59 398.52 471.54 300.63 255.87
Receivables
80.13 27.12 21.18 16.65 15.91 33.07 19.44 12.66 13.87 18.51
Inventory
5.88 6.20 9.41 4.52 7.31 7.61 6.08 5.62 5.35 2.83
Total current assets
437.57 416.70 616.78 486.44 582.83 410.41 429.06 495.68 325.81 332.35
Property, Plant, Equpment (Net)
4.02 5.34 7.48 9.05 11.11 9.42 2.89 3.15 3.23 2.59
Long-Term Investments
— — — — — — — 15.00 — —
Goodwill and Intangible Assets (Total)
113.87 103.97 104.44 97.07 148.44 154.13 158.14 187.63 185.75 182.98
Long-term assets (Other)
39.16 53.82 42.16 10.68 11.07 7.81 14.71 7.71 5.56 7.36
Total non-current assets
167.63 177.42 172.14 186.15 193.81 197.03 175.74 213.48 194.54 192.93
Total Assets
605.19 594.13 788.91 672.59 776.63 607.44 604.80 709.16 520.35 525.28
Notes Payable
— 68.68 — — — — — 22.46 — —
Accounts Payable
24.80 23.53 41.68 17.29 15.14 12.13 26.61 6.95 18.94 7.52
Accrued Expenses
126.04 86.03 118.99 95.74 75.18 56.79 51.75 49.70 36.02 33.31
Current Revenue (Deferred)
— 2.82 7.10 11.98 16.27 — — — — —
Other current liabilities
3.19 17.11 5.24 5.72 13.59 23.38 17.09 25.52 30.71 42.43
Total current liabilities
159.90 200.75 177.91 142.16 124.09 92.66 95.45 104.62 85.67 83.26
Long Term Debt (Total)
311.72 310.31 377.26 375.55 226.58 215.34 204.86 195.09 45.08 44.42
Non-current Revenue (Deferred)
— — 1.84 10.93 20.38 — — — — —
Long Term Tax Liability (Deferred)
— — — — — — — — (6.42) 6.43
Non-current Liabilities (Other)
7.60 6.80 10.32 9.39 71.98 59.89 83.29 91.20 96.47 83.41
Total non-current liabilities
330.46 334.30 410.20 487.57 350.43 303.57 288.16 286.29 141.54 134.25
Total liabilities
490.36 535.05 588.10 629.73 474.52 396.23 383.60 390.91 227.21 217.52
Additional Paid In Capital
1,588.72 1,506.32 1,327.88 1,059.98 1,068.63 797.99 636.91 589.80 471.80 421.31
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Retained Earnings
(1,472.71) (1,447.17) (1,125.62) (1,014.22) (765.97) (585.87) (416.44) (270.02) (177.65) (113.06)
Common Equity (Total)
114.83 59.08 200.81 42.85 302.11 211.21 221.20 318.25 293.13 307.77
Shareholders Equity (Total)
114.83 59.08 200.81 42.85 302.11 211.21 221.20 318.25 293.13 307.77
Shareholders Equity and Liabilities (Total)
605.19 594.13 788.91 672.59 776.63 607.44 604.80 709.16 520.35 525.28
Shares (Common)
90.92 87.45 75.37 64.29 62.49 52.25 43.09 41.39 39.37 37.91
Shareholders Equity (Tangible)
0.96 (44.90) 96.37 (54.22) 153.68 57.09 63.06 130.63 107.38 124.79
Net Debt
(11.07) (60.39) (189.59) (74.70) (326.30) (146.25) (193.66) (276.45) (255.55) (211.45)
Total Debt
311.72 310.31 377.26 375.55 226.58 215.34 204.86 195.09 45.08 44.42

Fold the line items

In millions of $ except per-share values · columns are period end dates